Welcome to our dedicated page for Wellchange Holdings Co SEC filings (Ticker: WCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Wellchange Holdings Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Wellchange Holdings Co's regulatory disclosures and financial reporting.
Wellchange Holdings Company Limited reported a chief financial officer transition and approved a new employment agreement. Mr. Chan Siu Leung, Gary resigned as CFO, effective when the board accepted his resignation on February 1, 2026. The board then appointed Ms. Lau Cheuk Wing as CFO with monthly compensation of HKD$30,000.00, documented in an agreement dated February 2, 2026. Ms. Lau, age 33, is a certified public accountant with over nine years of audit and accounting experience, including service as an Audit Manager at SHINEWING (HK) CPA Limited working with Hong Kong listed and private companies.
Wellchange Holdings Company Limited reported that Nasdaq granted an additional 180 calendar days, until April 27, 2026, to regain compliance with the minimum bid price requirement under Rule 5550(a)(2).
To regain compliance, the closing bid price of the company’s Class A ordinary shares must be at least $1.00 for a minimum of 10 consecutive business days during this period. The notice has no immediate impact on the listing; the shares will continue to trade on the Nasdaq Capital Market, subject to compliance with other listing requirements. Nasdaq initially cited a 33‑business‑day period of sub‑$1.00 bids from March 11 to April 25, 2025.
Wellchange Holdings Company Limited filed an amended Form 6-K, furnishing its Management’s Discussion and Analysis and unaudited interim consolidated financial statements for the six months ended June 30, 2025 and 2024. These are provided as Exhibit 99.1 (MD&A) and Exhibit 99.2 (financial statements).
The filing also includes Inline XBRL exhibits (101 series) and a cover page interactive data file (Exhibit 104).
Ni Saijun reports acquiring 25,000,000 Class A ordinary shares of Wellchange Holdings Co Ltd, representing 17.210% of the outstanding Class A shares as of the filing date. The purchase closed on 09/09/2025 at $0.04 per share for a total of $1,000,000, paid from the reporting person’s personal funds. The filing states the shares were bought for investment purposes and that the reporting person may, from time to time, seek to influence the issuer’s management and strategic direction, but currently has no specific plans for transactions described in the itemized list. The reporting person asserts sole voting and dispositive power over the shares and discloses no related agreements or recent trades in the past 60 days.
Chan Fuk Hing disclosed a purchase of 20,000,000 Class A Ordinary Shares of Wellchange Holdings Co Ltd, representing 13.768% of the company’s outstanding Class A shares. The shares were acquired on 09/09/2025 at $0.04 per share for an aggregate $800,000, paid from the reporting person’s personal funds. The filing states the shares were bought for investment purposes and that the reporting person may, from time to time, seek to influence management and strategic direction, but currently has no concrete plans that would trigger the specific transactions listed in the form. The report confirms sole voting and dispositive power over the shares and that no other arrangements or recent transactions affecting the holding were reported.
Chan Cheung Hing filed a Schedule 13D reporting the acquisition of 40,000,000 Class A ordinary shares of Wellchange Holdings Co Ltd, representing 27.536% of the outstanding Class A shares. The shares were purchased on 09/09/2025 at $0.04 per share for an aggregate price of $1,600,000, paid from the reporting person’s personal funds. The filing states the shares were acquired for investment purposes and that the reporting person may, from time to time, seek to influence the issuer’s management and strategic direction; no present plans for transactions listed in the filing are disclosed. The reporting person asserts sole voting and dispositive power over the reported shares and confirms no transactions in the class occurred in the prior sixty days.
Wellchange Holdings Company Limited completed a private placement of 100,000,000 Class A ordinary shares at $0.04 per share, raising gross proceeds of $4,000,000. The shares were sold to accredited investors and qualified institutional buyers under U.S. securities law exemptions.
The company plans to use the cash for general corporate purposes, which may include acquisitions and working capital. Wellchange agreed to seek registration of the resale of these shares within sixty days of closing and to pay a placement fee of 3.5% of gross proceeds plus specified escrow and marketing fees.
Wellchange Holdings Company Limited reported two additions to its board of directors. Ms. Fang Li Chieh, founder and Chief Financial Officer of Taiwan-based Fortune Pioneer International Co., Ltd. and founder of Inspire Medical Corp., was appointed as a director on September 5, 2025. She has extensive entrepreneurial and professional credentials in finance, insurance, real estate, and securities, and will receive annual director compensation of US$36,000.
On September 4, 2025, the company appointed Mr. Shi Zhu as an independent director. He is a former senior official at China’s Ministry of Commerce and serves on multiple Hong Kong-listed company boards, with experience across international trade, asset management, corporate governance, M&A, capital markets, and blockchain. Mr. Shi will receive annual compensation of US$20,000. Following these appointments, the board remains composed of a majority of independent directors.
Wellchange Holdings held its annual general meeting on August 7, 2025, with 29,619,411 shares present (approximately 55.60% of 53,265,000 outstanding as of the July 18, 2025 record date), forming a quorum. Shareholders approved all board-recommended matters: re-appointment of five directors; a special resolution to redesignate authorized capital into a dual-class structure of 900,000,000 Class A shares (1 vote each) and 100,000,000 Class B shares (35 votes each), with Mr. Shek Kin Pong’s 5,000,000 and Power Smart International Limited’s 3,000,000 ordinary shares to convert into Class B; adoption of the Fourth Amended and Restated Memorandum and Articles of Association; authorization for a share consolidation at a board-determined ratio between 5-for-1 and 50-for-1; an increase in post-consolidation authorized capital as applicable; and related filings. The Amended and Restated Memorandum and Articles of Association is filed as Exhibit 3.1.
Wellchange Holdings Company Limited ("WCT") has filed a Form 6-K outlining the adoption and first use of its 2025 Equity Incentive Plan.
Key elements disclosed include:
- Plan Adoption: On 1 June 2025 the company adopted the 2025 Equity Incentive Plan to issue share-based awards to employees, directors and consultants. The plan authorises up to 7,000,000 ordinary shares.
- Major Grant: On 23 June 2025 the Compensation Committee and Board approved a grant of 5,000,000 ordinary shares (≈ 71% of the plan’s capacity) to Chief Executive Officer & Chairman Mr. Shek Kin Pong in recognition of his continued service.
- Vesting & Lock-up: The shares are immediately vested upon acceptance but are subject to a three-year lock-up period, restricting transfers until June 2028.
- Issuance Mechanics: Shares were issued pursuant to the 2025 Incentive Plan and are covered by the company’s Form S-8 registration statement (No. 333-287845).
The filing contains no financial statements or earnings data. While the award aligns the CEO’s interests with shareholders, it utilises a significant portion of the authorised share pool and introduces potential dilution for existing shareholders.